Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription Articles published in Nat Med Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

May 2019
1. ARDILA D, Kiraly AP, Bharadwaj S, Choi B, et al
   End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.
   Nat Med. 2019 May 20. pii: 10.1038/s41591-019-0447.
   PubMed     Text format     Abstract available
   
   
   March 2019
2. ABBOTT B
   Spreading the search.
   Nat Med. 2019;25:352-355.
   PubMed     Text format    
   
   
   January 2019
3. TEIXEIRA VH, Pipinikas CP, Pennycuick A, Lee-Six H, et al
   Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.
   Nat Med. 2019 Jan 21. pii: 10.1038/s41591-018-0323.
   PubMed     Text format     Abstract available
   
   
   November 2018
4. SHAH KN, Bhatt R, Rotow J, Rohrberg J, et al
   Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.
   Nat Med. 2018 Nov 26. pii: 10.1038/s41591-018-0264.
   PubMed     Text format     Abstract available
   
   
   
5. FORMENTI SC, Rudqvist NP, Golden E, Cooper B, et al
   Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
   Nat Med. 2018 Nov 5. pii: 10.1038/s41591-018-0232.
   PubMed     Text format     Abstract available
   
   
   September 2018
6. COUDRAY N, Ocampo PS, Sakellaropoulos T, Narula N, et al
   Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
   Nat Med. 2018 Sep 17. pii: 10.1038/s41591-018-0177.
   PubMed     Text format     Abstract available
   
   
   August 2018
7. DERIBE YL, Sun Y, Terranova C, Khan F, et al
   Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
   Nat Med. 2018 Aug 13. pii: 10.1038/s41591-018-0173.
   PubMed     Text format     Abstract available
   
   
   
8. HOYLES L, Fernandez-Real JM, Federici M, Serino M, et al
   Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
   Nat Med. 2018 Aug 9. pii: 10.1038/s41591-018-0169.
   PubMed     Text format     Abstract available
   
   
   
9. GUO X, Zhang Y, Zheng L, Zheng C, et al
   Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
   Nat Med. 2018 Aug 9. pii: 10.1038/s41591-018-0167.
   PubMed     Text format     Abstract available
   
   
   
10. GANDARA DR, Paul SM, Kowanetz M, Schleifman E, et al
    Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
    Nat Med. 2018 Aug 6. pii: 10.1038/s41591-018-0134.
    PubMed     Text format     Abstract available
    
    
    June 2018
11. GUO X, Zhang Y, Zheng L, Zheng C, et al
    Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Nat Med. 2018 Jun 25. pii: 10.1038/s41591-018-0045.
    PubMed     Text format     Abstract available
    
    
    
12. THOMMEN DS, Koelzer VH, Herzig P, Roller A, et al
    A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.
    Nat Med. 2018 Jun 11. pii: 10.1038/s41591-018-0057.
    PubMed     Text format     Abstract available
    
    
    
13. LISSANU DERIBE Y, Sun Y, Terranova C, Khan F, et al
    Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
    Nat Med. 2018 Jun 8. pii: 10.1038/s41591-018-0019.
    PubMed     Text format     Abstract available
    
    
    May 2018
14. MAINARDI S, Mulero-Sanchez A, Prahallad A, Germano G, et al
    SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo.
    Nat Med. 2018 May 28. pii: 10.1038/s41591-018-0023.
    PubMed     Text format     Abstract available
    
    
    April 2018
15. ROBICHAUX JP, Elamin YY, Tan Z, Carter BW, et al
    Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
    Nat Med. 2018 Apr 23. pii: 10.1038/s41591-018-0007.
    PubMed     Text format     Abstract available
    
    
    March 2018
16. DARDAEI L, Wang HQ, Singh M, Fordjour P, et al
    SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
    Nat Med. 2018 Mar 5. pii: nm.4497. doi: 10.1038/nm.4497.
    PubMed     Text format     Abstract available
    
    
    October 2017
17. ROMERO R, Sayin VI, Davidson SM, Bauer MR, et al
    Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.
    Nat Med. 2017 Oct 2. doi: 10.1038/nm.4407.
    PubMed     Text format     Abstract available
    
    
    August 2017
18. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available
    
    
    July 2017
19. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available
    
    
    June 2017
20. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: